Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 1,118 0.27%
02 Jun - close price
anupamrasayan.com BSE: 543275 NSE : ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Life Science Specialty Chemicals (~92% revenues)
Under the vertical, the company offers various specialty chemicals across various categories :-
a. Agrochemicals - insecticides, fungicides, herbicides and plant growth regulators.
b. Personal Care - antibacterial and ultraviolet protection intermediates and ingredients.
c. Pharmaceuticals - developing of intermediates and key starting materials for APIs.[1]

Website BSE NSE
  • Market Cap ₹ 12,018 Cr.
  • Current Price ₹ 1,118
  • High / Low ₹ 1,250 / 547
  • Stock P/E 71.3
  • Book Value ₹ 220
  • Dividend Yield 0.22 %
  • ROCE 10.6 %
  • ROE 8.25 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 34.2% CAGR over last 5 years

Cons

  • Stock is trading at 5.09 times its book value
  • Company has a low return on equity of 8.16% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
157 135 220 184 272 234 249 266 325 307 311 296 371
124 102 176 131 209 173 185 191 220 213 219 206 279
Operating Profit 33 33 44 53 63 60 63 75 105 94 92 89 92
OPM % 21% 24% 20% 29% 23% 26% 25% 28% 32% 31% 30% 30% 25%
8 -1 19 5 3 4 6 5 -8 -9 -2 -4 18
Interest 13 18 17 14 19 7 5 5 14 12 16 14 20
Depreciation 11 12 13 13 13 14 15 16 15 16 16 17 17
Profit before tax 16 2 33 31 33 44 50 60 67 57 58 54 74
Tax % 37% 86% 22% 31% 33% 27% 28% 36% 33% 34% 29% 29% 30%
Net Profit 10 0 26 21 22 32 36 38 45 37 41 39 51
EPS in Rs 2.09 0.05 5.03 2.49 2.22 3.20 3.59 3.79 4.50 3.73 4.11 3.61 4.77
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
107 228 273 288 288 343 502 529 811 1,066 1,284
86 179 204 208 218 269 408 394 618 770 917
Operating Profit 21 49 69 80 70 73 93 134 193 296 367
OPM % 19% 22% 25% 28% 24% 21% 19% 25% 24% 28% 29%
0 2 5 8 11 6 19 11 26 15 2
Interest 8 22 14 21 21 15 24 45 69 31 62
Depreciation 3 5 10 13 15 18 23 29 52 60 66
Profit before tax 10 24 50 54 45 48 66 71 99 220 242
Tax % 30% 23% 28% 21% 22% 19% 24% 26% 30% 32% 30%
Net Profit 7 18 36 43 35 39 50 53 70 151 169
EPS in Rs 7.29 18.45 7.27 8.53 6.96 7.73 10.05 10.60 7.00 15.04 15.69
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 7% 7% 13%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 34%
TTM: 20%
Compounded Profit Growth
10 Years: %
5 Years: 34%
3 Years: 47%
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 64%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 8%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 10 50 50 56 75 75 78 100 100 107
Reserves 23 61 58 97 194 382 432 515 1,473 1,624 2,252
56 117 144 279 312 425 662 818 423 836 822
20 29 51 55 76 122 170 280 300 325 388
Total Liabilities 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569
45 90 145 259 313 379 682 978 1,116 1,203 1,240
CWIP 1 1 21 64 88 250 183 101 42 43 113
Investments 1 0 2 2 2 2 0 0 0 148 158
61 126 134 157 230 347 449 583 1,137 1,492 2,057
Total Assets 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 51 68 69 17 -8 42 95 1 -171 244
-8 -38 -88 -168 -93 -247 -261 -178 -192 -412 -478
-1 11 9 100 73 254 209 102 416 384 376
Net Cash Flow 0 24 -10 0 -3 -0 -9 19 224 -199 142

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 45 48 36 28 71 94 88 89 92 96 106
Inventory Days 252 153 158 211 305 411 277 513 528 849 626
Days Payable 81 56 92 94 156 148 105 225 213 223 202
Cash Conversion Cycle 216 144 101 144 220 358 260 378 407 722 530
Working Capital Days 151 120 86 113 152 207 167 184 232 330 302
ROCE % 29% 22% 13% 9% 9% 9% 10% 11% 11%

Shareholding Pattern

Numbers in percentages

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
65.40 65.40 65.40 65.40 65.18 65.17 65.16 60.96 60.80
5.74 6.16 5.87 5.73 5.73 4.98 4.59 8.19 8.52
1.75 2.29 3.32 3.75 3.68 4.40 4.40 6.18 4.98
27.11 26.16 25.42 25.12 25.41 25.45 25.84 24.67 25.68

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls